PSMA Heterogeneity Analysis in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Imaging Versus CTCs.2019-05-28T09:03:46-07:00 PSMA Heterogeneity Analysis in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Imaging Versus CTCs.